Login / Signup
Xuemei Tao
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 3
Top Topics
Emergency Department
Adverse Drug
Hepatitis C Virus
Liver Fibrosis
Top Venues
Hepatology (Baltimore, Md.)
Journal of medical virology
Alimentary pharmacology & therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Lin Chen
,
Xuemei Tao
,
Minghui Zeng
,
Yuqin Li
,
Jiaxin Han
,
Yuekui Wang
,
Yonggang Liu
,
Ruifang Shi
,
Rui Su
,
Liang Xu
,
Yuqiang Mi
Noninvasive tests maintain high accuracy for advanced fibrosis in chronic hepatitis B patients with different nomenclatures of steatotic liver disease.
Journal of medical virology
96 (4) (2024)
Lin Chen
,
Xuemei Tao
,
Youfei Zhao
,
Minghui Zeng
,
Yuqiang Mi
,
Liang Xu
Letter: serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination.
Alimentary pharmacology & therapeutics
55 (8) (2022)
Xuemei Tao
,
Youfei Zhao
,
Lin Chen
,
Minghui Zeng
,
Yuqiang Mi
,
Liang Xu
Letter to the editor: Prediction of biochemical nonresolution in patients with chronic drug-induced liver injury: A large multicenter study.
Hepatology (Baltimore, Md.)
76 (1) (2022)